Inhalational anesthesia: basic pharmacology, end organ effects, and applications in the treatment of status asthmaticus.
The potent inhalational anesthetic agents are used on a daily basis to provide intraoperative anesthesia. Given their beneficial effects on airway tone and reactivity, they also have a role in the treatment of status asthmaticus that is refractory to standard therapy. Although generally not of clinical significance, these agents can affect various physiological functions. The potent inhalational anesthetic agents decrease mean arterial pressure and myocardial contractility. The decrease in mean arterial pressure reduces renal and hepatic blood flow. Secondary effects on end-organ function may result from the metabolism of these agents and the release of inorganic fluoride. The following article reviews the history of inhalational anesthesia, the physical structure of the inhalational anesthetic agents, their end-organ effects, reports of their use for the treatment of refractory status asthmaticus in the intensive care unit (ICU) patient, and special considerations for their administration in this setting including equipment for their delivery, scavenging, and monitoring.
Departments of Anesthesiology and Pediatrics, University of Missouri, Columbia, Missouri 01199, USA. Tobiasj@health.missouri.edu
Joseph D
JD
Tobias
D000280:Administration, Inhalation; D000769:Anesthesia, Inhalation / Q000379:methods*; D018685:Anesthetics, Inhalation / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D003422:Critical Care; D006801:Humans; D016343:Monitoring, Intraoperative; D009200:Myocardial Contraction / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D013224:Status Asthmaticus / Q000188:drug therapy* / Q000503:physiopathology
D018685:Anesthetics, Inhalation; D001993:Bronchodilator Agents